BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 12202993)

  • 21. Abnormal giant cells in the cerebral lesions of tuberous sclerosis complex.
    Mizuguchi M
    Congenit Anom (Kyoto); 2007 Mar; 47(1):2-8. PubMed ID: 17300684
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mutation analysis of the TSC1 and TSC2 genes in Japanese patients with pulmonary lymphangioleiomyomatosis.
    Sato T; Seyama K; Fujii H; Maruyama H; Setoguchi Y; Iwakami S; Fukuchi Y; Hino O
    J Hum Genet; 2002; 47(1):20-8. PubMed ID: 11829138
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel TSC2 mutations and decreased expression of tuberin in cultured tumor cells with an insertion mutation.
    Feng JH; Yamamoto T; Nanba E; Ninomiya H; Oka A; Ohno K
    Hum Mutat; 2004 Apr; 23(4):397. PubMed ID: 15024740
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The cellular response to ectopic overexpression of the tuberous sclerosis genes, TSC1 and TSC2: a proteomic approach.
    Hengstschläger M; Rosner M; Fountoulakis M; Lubec G
    Int J Oncol; 2005 Sep; 27(3):831-8. PubMed ID: 16077935
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The tuberous sclerosis genes and regulation of the cyclin-dependent kinase inhibitor p27.
    Rosner M; Freilinger A; Hengstschläger M
    Mutat Res; 2006 Sep; 613(1):10-6. PubMed ID: 16713332
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Localization of tuberous sclerosis 2 mRNA and its protein product tuberin in normal human brain and in cerebral lesions of patients with tuberous sclerosis.
    Kerfoot C; Wienecke R; Menchine M; Emelin J; Maize JC; Welsh CT; Norman MG; DeClue JE; Vinters HV
    Brain Pathol; 1996 Oct; 6(4):367-75. PubMed ID: 8944308
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of the TSC2 product tuberin and its target Rap1 in normal human tissues.
    Wienecke R; Maize JC; Reed JA; de Gunzburg J; Yeung RS; DeClue JE
    Am J Pathol; 1997 Jan; 150(1):43-50. PubMed ID: 9006320
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Morphology of cerebral lesions in the Eker rat model of tuberous sclerosis.
    Wenzel HJ; Patel LS; Robbins CA; Emmi A; Yeung RS; Schwartzkroin PA
    Acta Neuropathol; 2004 Aug; 108(2):97-108. PubMed ID: 15185103
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HMB-45 and tuberin in hamartomas associated with tuberous sclerosis.
    Kimura N; Watanabe M; Date F; Kitamoto T; Kumura I; Horii A; Nagura H
    Mod Pathol; 1997 Sep; 10(9):952-9. PubMed ID: 9310961
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mutation screening of the entire coding regions of the TSC1 and the TSC2 gene with the protein truncation test (PTT) identifies frequent splicing defects.
    Mayer K; Ballhausen W; Rott HD
    Hum Mutat; 1999; 14(5):401-11. PubMed ID: 10533066
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The tuberous sclerosis genes, TSC1 and TSC2, trigger different gene expression responses.
    Rosner M; Freilinger A; Lubec G; Hengstschläger M
    Int J Oncol; 2005 Nov; 27(5):1411-24. PubMed ID: 16211238
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The cell cycle and tuberous sclerosis.
    Hengstschläger M; Rosner M
    Prog Cell Cycle Res; 2003; 5():43-8. PubMed ID: 14593699
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Co-localization of TSC1 and TSC2 gene products in tubers of patients with tuberous sclerosis.
    Johnson MW; Emelin JK; Park SH; Vinters HV
    Brain Pathol; 1999 Jan; 9(1):45-54. PubMed ID: 9989450
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prenatal molecular diagnosis of tuberous sclerosis complex.
    Milunsky A; Ito M; Maher TA; Flynn M; Milunsky JM
    Am J Obstet Gynecol; 2009 Mar; 200(3):321.e1-6. PubMed ID: 19254590
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of tuberin and hamartin in tuberous sclerosis complex-associated and sporadic cortical dysplasia of Taylor's balloon cell type.
    Grajkowska W; Kotulska K; Matyja E; Larysz-Brysz M; Mandera M; Roszkowski M; Domańska-Pakieła D; Lewik-Kowalik J; Jóźwiak S
    Folia Neuropathol; 2008; 46(1):43-8. PubMed ID: 18368626
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The tuberous sclerosis gene products hamartin and tuberin are multifunctional proteins with a wide spectrum of interacting partners.
    Rosner M; Hanneder M; Siegel N; Valli A; Hengstschläger M
    Mutat Res; 2008; 658(3):234-46. PubMed ID: 18291711
    [TBL] [Abstract][Full Text] [Related]  

  • 37. TSC2 missense mutations inhibit tuberin phosphorylation and prevent formation of the tuberin-hamartin complex.
    Nellist M; Verhaaf B; Goedbloed MA; Reuser AJ; van den Ouweland AM; Halley DJ
    Hum Mol Genet; 2001 Dec; 10(25):2889-98. PubMed ID: 11741832
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pathological mutations in TSC1 and TSC2 disrupt the interaction between hamartin and tuberin.
    Hodges AK; Li S; Maynard J; Parry L; Braverman R; Cheadle JP; DeClue JE; Sampson JR
    Hum Mol Genet; 2001 Dec; 10(25):2899-905. PubMed ID: 11741833
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Altered cellular distribution of tuberin and glucocorticoid receptor in sporadic fundic gland polyps.
    Wei J; Chiriboga L; Yee H; Mizuguchi M; Li E; Sidhu GS; West AB
    Mod Pathol; 2002 Aug; 15(8):862-9. PubMed ID: 12181272
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evidence for separable functions of tuberous sclerosis gene products in mammalian cell cycle regulation.
    Miloloza A; Kubista M; Rosner M; Hengstschläger M
    J Neuropathol Exp Neurol; 2002 Feb; 61(2):154-63. PubMed ID: 11853018
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.